Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Hemasphere|October 6, 2023
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated PatientsVictoria Panagiota, Johanna Franziska Kerschbaum, Olaf Penack, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Blood|January 14, 2018
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit J Schuurhuis, Michael Heuser, Sylvie Freeman, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Leukemia & Lymphoma|July 29, 2021
A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemiaKendra Sweet, Bhavana Bhatnagar, Hartmut Döhner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2017
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell TransplantationNicolaus Kröger, Victoria Panagiota, Anita Badbaran, et al.
Blood|June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cellsFlorian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
American Journal of Hematology|March 16, 2021
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5qVictoria Panagiota, Manja Meggendorfer, Anne Sophie Kubasch, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Hemasphere|October 6, 2023
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated PatientsVictoria Panagiota, Johanna Franziska Kerschbaum, Olaf Penack, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Blood|January 14, 2018
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit J Schuurhuis, Michael Heuser, Sylvie Freeman, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Leukemia & Lymphoma|July 29, 2021
A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemiaKendra Sweet, Bhavana Bhatnagar, Hartmut Döhner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2017
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell TransplantationNicolaus Kröger, Victoria Panagiota, Anita Badbaran, et al.
Blood|June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cellsFlorian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
American Journal of Hematology|March 16, 2021
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5qVictoria Panagiota, Manja Meggendorfer, Anne Sophie Kubasch, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Pageof 28